We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$1.85B
AUM Growth
-$178M
Cap. Flow
-$224M
Cap. Flow %
-12.14%
Top 10 Hldgs %
25.27%
Holding
470
New
153
Increased
56
Reduced
66
Closed
179

Top Sells

Rank Stock Value
1
RAI
Reynolds American Inc
RAI
+$35.8M
2
SJM icon
J.M. Smucker
SJM
+$30.8M
3
PYPL icon
PayPal
PYPL
+$23.4M
4
MSFT icon
Microsoft
MSFT
+$19.3M
5
NXPI icon
NXP Semiconductors
NXPI
+$18.1M

Sector Composition

Rank Sector Weight
1 Technology 8.09%
2 Consumer Discretionary 6.98%
3 Industrials 6.35%
4 Communication Services 6.01%
5 Healthcare 3.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVD icon
201
American Vanguard Corp
AVD
$73.5M
$1.32M 0.07%
76,500
-3,750
-5% -$64.6K
IRBT
202
PUT
DELISTED
iRobot
IRBT
$1.26M 0.07%
+15,000
New +$1.29M
ESRX
203
CALL
DELISTED
Express Scripts Holding Company
ESRX
$1.25M 0.07%
19,500
WU icon
204
PUT
Western Union
WU
$2.57B
$1.24M 0.07%
+65,000
New +$1.26M
CTRL
205
DELISTED
Control4 Corporation
CTRL
$1.15M 0.06%
+58,800
New +$1.06M
SRPT icon
206
Sarepta Therapeutics
SRPT
$1.66B
$1.15M 0.06%
34,100
+25,600
+301% +$834K
WMT icon
207
PUT
Walmart Inc
WMT
$871B
$1.14M 0.06%
+45,000
New +$1.14M
XRT icon
208
State Street SPDR S&P Retail ETF
XRT
$365M
$1.12M 0.06%
27,500
-105,000
-79% -$4.36M
STML
209
DELISTED
Stemline Therapeutics, Inc.
STML
$1.1M 0.06%
120,000
-20,000
-14% -$167K
PI icon
210
CALL
Impinj
PI
$3.89B
$1.09M 0.06%
+22,500
New +$945K
PENN icon
211
CALL
PENN Entertainment
PENN
$2.74B
$1.07M 0.06%
+50,000
New +$983K
ITCI
212
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.05M 0.06%
+84,200
New +$976K
CBPX
213
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$1.03M 0.06%
+44,148
New +$1.07M
HD icon
214
Home Depot
HD
$332B
$1.03M 0.06%
+6,700
New +$1.03M
POT
215
DELISTED
Potash Corp Of Saskatchewan
POT
$993K 0.05%
60,900
+23,100
+61% +$382K
TJX icon
216
TJX Companies
TJX
$170B
$960K 0.05%
+26,600
New +$1M
ZGNX
217
DELISTED
Zogenix, Inc.
ZGNX
$943K 0.05%
65,000
-180,846
-74% -$2.27M
NGVC icon
218
Vitamin Cottage Natural Grocers
NGVC
$691M
$937K 0.05%
+113,299
New +$1.11M
PRKS icon
219
United Parks & Resorts
PRKS
$2.11B
$891K 0.05%
+54,760
New +$941K
TLRD
220
CALL
DELISTED
Tailored Brands, Inc.
TLRD
$837K 0.05%
+75,000
New +$877K
KS
221
DELISTED
KapStone Paper and Pack Corp.
KS
$831K 0.05%
40,300
+36,200
+883% +$779K
DFIN icon
222
Donnelley Financial Solutions
DFIN
$1.21B
$804K 0.04%
+35,000
New +$766K
CZR icon
223
CALL
Caesars Entertainment
CZR
$6.1B
$800K 0.04%
+40,000
New +$800K
SHOP icon
224
Shopify
SHOP
$148B
$782K 0.04%
+90,000
New +$761K
BLUE
225
DELISTED
bluebird bio
BLUE
$772K 0.04%
567
-730
-56% -$881K

Similar funds

J. Goldman & Co's Q2 2017 Portfolio in Review

As of Q2 2017, J. Goldman & Co held 470 positions worth $1.85B, down 8.8% from $2.02B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

J. Goldman & Co withdrew a net $224M in Q2 2017, closing 179 positions and reducing 66 holdings. Its most notable exit was Reynolds American Inc, an estimated $35.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 7.9% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, J. Goldman & Co opened a new position in Altaba Inc worth $28.8M.

  • J. Goldman & Co's largest Q2 2017 buy was Altaba Inc: 528,039 shares worth $28.8M.
  • J. Goldman & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2017, an estimated $17.6M increase.
  • J. Goldman & Co's biggest Q2 2017 reduction was PayPal, cutting an estimated $23.4M.
  • J. Goldman & Co fully exited Reynolds American Inc in Q2 2017, selling an estimated $35.8M.
  • J. Goldman & Co's ten largest holdings make up 25% of its $1.85B portfolio in Q2 2017.
  • J. Goldman & Co opened 153 new positions and closed 179 in Q2 2017.
  • J. Goldman & Co's portfolio value fell 8.8% quarter-over-quarter to $1.85B.

Based on J. Goldman & Co's 13F filing for Q2 2017, filed 14 Aug 2017.